Sandor Vari, MD, Managing Director of VARIMED, Variable Medicine Limited Liability Company
Dr. Sandor G. Vari received his medical doctor degree in 1978, Budapest, Hungary. From 1978 through March 1988, Dr. Vari worked at Semmelweis Medical University, 1st Department of Surgery, Budapest. After successfully passing the exam, he was admitted to the surgical board (No1313/1985). He completed his surgical residency from 1978 to 1983 at the 1st Department of Surgery and from 1985 he attended a training rotation in the fields of surgery, traumatology, and post-operative surgical intensive care. From 1985 through 1990 he held the position of assistant professor of surgery at Semmelweis Medical University Budapest, Hungary.
In 1988, he received a fellowship from Brig Research Ltd., to study laser-tissue interactions at the Laser Research and Technology Development Department, Cedars-Sinai Medical Center, Los Angeles, CA.
In 1989 he received a Fulbright scholarship to study biomedical photonics at the same place.
In 1994 Foundation Research and Technology HELLAS (FORTH) Institute of Electronic Structure and Lasers, Crete, Greece invited him to organize a biomedical optics group.
From 1995 to 1997 he worked at the Laser-und Medizin -Technologie gGmbh, Berlin as a contractor and scientific coordinator.
His academic productivity is documented by 13 articles in peer-reviewed journals, 34 articles in edited journals and conference proceeding, and more than 46 abstracts and numerous scientific presentations related to work that has been presented by him personally and his colleagues at meetings all over the world. Dr. Vari has been granted five US patents which signifies the importance of his scientific work.
Dr. Vari's innovative work has been rewarded by several prestigious research grants, which include 7 from the National Institutes of Health- Small Business Innovative Research (SBIR) Program Grants, one from the Department of Defense-SBIR, and several from industrial sources. In Europe was coordinating or managing 6 projects in the field of biotechnology and the area of healthcare telematics; “Colposcopic Imaging Spectroscopy”, COLPIS Contract # ERBIC15CT960815 (DGXII), “Interactive Histopathology Consultation Network”, INTERPATH PL961121, and “Primary Care Physicians Communication Network”, PRIMACOM PL961090 (DGXIII) “Regional and International Integrated Telemedicine Network for Medical Assistance in the End Stage Disease and Organ Transplant”, RETRANSPLANT EC (DGXIII) n° 3236, Professional Development Concerning General Practitioner, ROPRACTITION, European Commission Education and Culture Directorate General. HU/99/1/083138/PI/III.3.a., Enabling Best Practices in Oncology BEPRO European Commission - Directorate Generale XIII, IST2000 Take Up Actions: IST-2000-25252. He was an invited independent expert for the European Commission, Directorate-General XIII, Telematics Applications Programme for Healthcare and he is still working for Directorate General Research.
In 1996 Dr. Vari founded VARIMED, Variable Medicine, Limited Liability Company. VARIMED is one of the first companies in Central & Eastern Europe which is recognizing the market imperfections in the field of biomedical technologies. As a research and technology development and transfer company VARIMED provides not only the latest technology in biomedical science and informatics, medical imaging, and less invasive out-patient medical technology, but also allows the physician to be efficient without compromising the quality of providing healthcare.
He is currently Director of the International Research and Innovation Management Program (http://www.csmc.edu/innovationtechnology) at Cedars – Sinai Medical Center, Los Angeles, California, USA.
In 1998 Dr. Vari established the Innovation Management and Technology Transfer Program (IMTT) at the Medical Center to provide assistance to Central and Eastern European Universities and Research Organizations in the development of institutional policies and procedures and laying the foundation for the management of their scientific and intellectual assets. This program was originally implemented with three medical universities in Hungary and expanded throughout Central and East Europe.
In autumn of 2003, with the leadership of Dr. Vari the Medical Center, along with the Fogarty International Center at the National Institutes of Health, hosted the “Bridges in Life Sciences” symposium, presenting topics such as grantsmanship, and innovation management and research collaborations to participants from over ten countries (http://www.varimed.hu/ Conference). The meeting’s aim was to bring together biomedical and behavioural researchers from the Central and Eastern European (CEE) region and their U.S. counterparts to highlight collaborations supported by the NIH, as well as by the EU, in an effort to initiate a dialogue on how the collective collaborations could be strengthened, in the context of the continuing transition in this region. A secondary aim was to develop the participating universities’ and institutes’ capacity in technology transfer to bring promising research results from CEE into the development phase and to market.
From 2003 the Bridges in Life Sciences meeting concept has been presented all over CEE in academic and research institutions in Bulgaria, Croatia, Czech Republic, Hungary, Lithuania, Poland, Romania, Slovakia, Slovenia and Ukraine with great success, emphasizing the notion that research has no borders.
In 2000 Dr. Vari started to execute the Medical Center’s educational program for research and innovation management and intellectual property protection in the Czech Republic, Hungary, Romania, Slovak Republic and Ukraine. In the execution of the IMTT Training Program, there are three different stages: INTRODUCE, INVOLVE, IMPLEMENT. Each stage also anticipates various levels of education and training activities for the partner university.
In 2000 Dr. Vari and Dr. Calvin Hobel from CSMC initiated also a collaborative to investigate the complexity of low birth weight (LBW). Dr. Vari organized four meetings to formulate plans for the building of a research collaborative with representatives from 15 countries. The presentations/discussions focused on three components of the LBW problem: preterm birth (PTB), intrauterine growth retardation (IUGR), and preeclampsia. During the REPRODUCTIVE Consortium Meetings (I-IV) it was recognized that researchers in the Central and Eastern European countries were interested in developing a research agenda with investigators at Cedars-Sinai, which lead to the first of many collaborative programs over the past 6 years.
In 2005 Dr. Vari got a training grant from the US Department of Commerce, Special American Business Internship Training (SABIT) for Medical Research and Innovation Management Training and organized training for 8 managers from four Ukrainian Academic Institutes.
Dr. Vari played a key role in the construction of a successful strategic partnership with Central and Eastern European Universities and Academic Organizations. In April 2006 with the leadership of Dr. Vari the Medical Center and twelve Central and Eastern European academic organizations formed the Regional Cooperation for Health, Science and Technology (RECOOP HST) Consortium. RECOOP HST provides the opportunity of cross-fertilization between researchers of different origin. The business model of the Consortium was created by Dr. Vari would generate income from the scientific work and related biotechnologies produced by Partners of the Consortium.